Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enoxaparin timing in pregnant women with APS
NCT02326051Phase 4Completed
- Start
- Dec 2014
- Primary completion
- Feb 2017
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of enoxaparin in antiphospholipid syndrome (APS) and recurrent miscarriage (RPL) (2 arms). Primary endpoint: Ongoing pregnancy rate. Started Dec 2014; status: completed.
02
Drugs
enoxaparin
03
Conditions
antiphospholipid syndrome (APS)recurrent miscarriage (RPL)
Beyond the preview
Go deeper on NCT02326051.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02326051.